Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-13-025266
Filing Date
2013-04-30
Accepted
2013-04-30 17:14:27
Documents
8
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A v343209_10ka.htm 10-K/A 874501
2 EXHIBIT 23 v343209_ex23.htm EX-23 3297
3 EXHIBIT 31.1 v343209_ex31-1.htm EX-31.1 9259
4 EXHIBIT 32.1 v343209_ex32-1.htm EX-32.1 5369
5 GRAPHIC image_005.gif GRAPHIC 75
6 GRAPHIC tpg12.jpg GRAPHIC 100305
7 GRAPHIC tpg7.jpg GRAPHIC 115135
8 GRAPHIC tpg8.jpg GRAPHIC 89087
  Complete submission text file 0001144204-13-025266.txt   1313666
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

EIN.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35737 | Film No.: 13798943
SIC: 2834 Pharmaceutical Preparations